Print Page

Ocumetics Bionic Eye Lens Updates

- Content Writer/Editor for Disabled World
Published: 2022/09/07 - Updated: 2024/01/11
Publication Type: News
Topic: Biometrics (Publications Database)

Page Content: Synopsis Definition Introduction Main Item

Synopsis: Studies and clinical trial news releases and updates in regards to the Ocumetics Bionic Lens. In 2012, Ocumetics Technology Corp., a Canadian-based research and product development company, was established to produce vision enhancement products and services through advanced refractive technologies invented and developed by Dr. Garth Webb. Ocumetics is developing new lens technology, which is expected to efficiently link electrical impulses with the natural mechanisms for accommodation within the human eye.

Introduction

Imagine being able to see three times better than 20/20 vision without wearing glasses or contacts, even at 100-plus years old, with the help of bionic lenses implanted in your eyes. Imagine seeing the minor details from 30 feet away instead of only 10 feet, such as signs or the clock's time. Futuristic, but possible with the Ocumetics Bionic Lens™.

Main Item

In 2012, Ocumetics Technology Corp., a Canadian-based research and product development company, was established to produce vision enhancement products and services through advanced refractive technologies invented and developed by Dr. Garth Webb.

Currently, Ocumetics is developing ground-breaking technological advancements for the ophthalmic industry through disruptive technological design in the Bionic Lens™. Its patented design may address many shortcomings of other surgeries and lens replacement options. The Bionic Lens™ is the first to help people recover normal vision at all viewing distances without requiring eyeglasses and lag time in focus.

Ocumetics is developing new lens technology, which is expected to efficiently link electrical impulses with the natural mechanisms for accommodation within the human eye. Through the Bionic Lens™, Ocumetics' goals of contributing to improving quality of life while ensuring that safety and efficacy remain central to every facet relevant to patient care are closer to being realized.

Webb says people with the specialized lenses surgically inserted would never get cataracts because their natural lenses, which decay over time, would have been replaced. He says the painless procedure, identical to cataract surgery, would take about eight minutes, and a patient's sight would be immediately corrected.

Other future possibilities for the Bionic Lens may include:

Human Eye Diagram

Continued below image.
This diagram shows a labeled basic structure of the human eye with the three main layers - image courtesy of Wikimedia Commons, Artwork by Holly Fischer.
This diagram shows a labeled basic structure of the human eye with the three main layers - image courtesy of Wikimedia Commons, Artwork by Holly Fischer.
Continued...

Bionic Lens Updates

May 18, 2022 : Ocumetics Update on the Status of Preclinical Studies for the Bionic Lens

Since January 2022, Ocumetics has been busy undertaking studies using cadaver donor eyes to determine how Ocumetics' optical technologies would fit in the human eye. These studies have led to design enhancements to perfect how the Bionic Lens conforms to the lens capsular bag of the human eye.

The studies, and resulting design enhancements, were supervised by Ocumetics' regulatory approval expert, Dr. Barbara Fant, Ocumetics' founder and Chief Scientific Officer, Dr. Garth Webb, and Chief Medical Officer, Dr. Doyle Stulting.

"We are focused on perfecting the design of the lens technology before we begin the regulatory approval process, which we expect will begin shortly," said Dr. Barbara Fant.

Dr. Garth Webb added:

"We have been experimenting with different lens materials and combinations thereof to ensure we have optimized the quality of the optics and the accommodation levels we are seeking in the lens technology. We have also been experimenting with different lens injectors to ensure the ophthalmologist can maintain control of the injection process during surgery."

The ergonomics of installing the optical technologies has also been an emphasis over the past 4-6 weeks.

"We have received excellent feedback from the ophthalmologists performing the cadaver surgeries," says Dr. Doyle Stulting. "We have used this feedback to ensure that inserting the Bionic Lens into the eye is as easy and intuitive as possible. If ophthalmologists enjoy the surgical process of installing the Bionic Lens into the patient's eye, they are much more likely to recommend Ocumetics products to their patients."

"It has been a busy few months since our last update," said Ocumetics CEO, Dr. Mark Lee. "We could not be happier with the progress being made. Moreover, we remain on target for the first human study, the Proof of Concept, to begin later this fall. All-in-all, very encouraging news for our investors and the future users of Ocumetics' optical technologies."

January 10, 2022 : Ocumetics Update on the Status of Preclinical Studies for the Bionic Lens

The preclinical studies for the Bionic Lens, consisting of the lens retainer and the lens itself, commenced on October 22, 2021. The preclinical studies are planned in three stages:

The Three Stages of Preclinical Studies
StageDescriptionStatusExpected completion
1 Test the Bionic Lens retainer for structural integrity and ease of insertion by the surgeon. Commenced Oct 22/21. Analysis completed in October 2021. Study completed Oct/21. Design improvements completed Dec/21.
2 Test the Bionic lens retainer with a standard lens used in a typical cataract procedure. Scheduled to begin February 25, 2022. Research report expected June/22.
3 Test the Bionic Lens retainer and optic element together. Scheduled to begin March 25, 2022. Research report expected June/22.

"Our research team has planned three stages of preclinical studies to test the two components of the Bionic Lens technology - the retainer and the optic element," said Dr. Mark Lee, President & CEO of Ocumetics. "Each of these components is considered a stand-alone medical device, which will be tested separately to meet regulatory approval requirements."

"We are pleased with the learnings obtained from the first stage of our preclinical studies," adds Dr. Lee. "We obtained invaluable data from our Stage 1 work that we used to refine the design of the Bionic Lens technology to 1) enhance the functioning of the lens in the eye and 2) to streamline the Bionic Lens surgical procedure."

Successful preclinical studies will be followed by Phase 1 human clinical trials, starting with a planned Proof-of-Concept study in the Fall of 2022.

Ocumetics

Ocumetics Technology Corp. is a Canadian research and product development company that specializes in adaptive lens designs. Ocumetics is in the preclinical study stage of a game-changing technology for the ophthalmic industry - the Bionic Lens. The Bionic Lens is an expandable intraocular lens that fits within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses. It allows the eye's natural muscle activity to shift focus from distance to near.

Dr. Garth Webb - Founder of Ocumetics Technology Corporation

Dr. Garth Webb has an inherent background in the science of sight. With over 40 years of optometry experience, Dr. Webb shifted his attention to product development and soon after became the sole innovator of the Bionic Lens. Coining the term "Human Visual Experience", he has completely changed the way people once viewed virtual reality through integration of basic science with physiological options and digital communications.

Explore Similar Topics

1 - - Studies and clinical trial news releases and updates in regards to the Ocumetics Bionic Lens.

2 - - Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds.

3 - - Researchers use 3D facial scans to aid diagnosis of children with Phelan-McDermid syndrome a rare genetic condition that causes intellectual and physical disabilities.

Complete Publications Database

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Langtree, I. C. (2022, September 7 - Last revised: 2024, January 11). Ocumetics Bionic Eye Lens Updates. Disabled World. Retrieved November 14, 2024 from www.disabled-world.com/assistivedevices/biometrics/bionic-lens.php

Permalink: <a href="https://www.disabled-world.com/assistivedevices/biometrics/bionic-lens.php">Ocumetics Bionic Eye Lens Updates</a>: Studies and clinical trial news releases and updates in regards to the Ocumetics Bionic Lens.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.